These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14750092)

  • 21. Immunosuppressive therapies for the induction treatment of proliferative lupus nephritis: a systematic review and network metaanalysis.
    Tian SY; Feldman BM; Beyene J; Brown PE; Uleryk EM; Silverman ED
    J Rheumatol; 2014 Oct; 41(10):1998-2007. PubMed ID: 25225281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
    Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; Garrido Ed Ede R; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
    Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppressive treatment for proliferative lupus nephritis.
    Tunnicliffe DJ; Palmer SC; Henderson L; Masson P; Craig JC; Tong A; Singh-Grewal D; Flanc RS; Roberts MA; Webster AC; Strippoli GF
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD002922. PubMed ID: 29957821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective analysis of nephritis response and renal outcome in a cohort of 928 Egyptian lupus nephritis patients: a university hospital experience.
    Momtaz M; Fayed A; Wadie M; Gamal SM; Ghoniem SA; Sobhy N; Kamal Elden NM; Hamza WM
    Lupus; 2017 Dec; 26(14):1564-1570. PubMed ID: 28625079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low risk of renal flares and negative outcomes in women with lupus nephritis conceiving after switching from mycophenolate mofetil to azathioprine.
    Fischer-Betz R; Specker C; Brinks R; Aringer M; Schneider M
    Rheumatology (Oxford); 2013 Jun; 52(6):1070-6. PubMed ID: 23382355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis.
    Mejía-Vilet JM; Arreola-Guerra JM; Córdova-Sánchez BM; Morales-Buenrostro LE; Uribe-Uribe NO; Correa-Rotter R
    J Rheumatol; 2015 Nov; 42(11):2082-91. PubMed ID: 26373566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts.
    Ruiz-Irastorza G; Ugarte A; Saint-Pastou Terrier C; Lazaro E; Iza A; Couzi L; Saenz R; Richez C; Porta S; Blanco P
    Autoimmun Rev; 2017 Aug; 16(8):826-832. PubMed ID: 28564619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of mycophenolate mofetil in adolescent patients with lupus nephritis: evidence from a two-phase, prospective randomized trial.
    Sundel R; Solomons N; Lisk L;
    Lupus; 2012 Nov; 21(13):1433-43. PubMed ID: 22922564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of maintenance therapy with tacrolimus versus azathioprine for active lupus nephritis: a multicenter randomized clinical trial.
    Chen W; Liu Q; Chen W; Tang X; Fu P; Liu F; Liao Y; Yang Z; Zhang J; Chen J; Lou T; Fu J; Kong Y; Liu Z; Li Z; Yu X
    Lupus; 2012 Aug; 21(9):944-52. PubMed ID: 22438027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enteric-coated mycophenolate sodium versus azathioprine in patients with active systemic lupus erythematosus: a randomised clinical trial.
    Ordi-Ros J; Sáez-Comet L; Pérez-Conesa M; Vidal X; Mitjavila F; Castro Salomó A; Cuquet Pedragosa J; Ortiz-Santamaria V; Mauri Plana M; Cortés-Hernández J
    Ann Rheum Dis; 2017 Sep; 76(9):1575-1582. PubMed ID: 28450313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of lupus nephritis in children.
    Niaudet P
    Pediatr Nephrol; 2000 Feb; 14(2):158-66. PubMed ID: 10684369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential therapy for diffuse proliferative and membranous lupus nephritis: cyclophosphamide and prednisolone followed by azathioprine and prednisolone.
    Chan TM; Li FK; Wong RW; Wong KL; Chan KW; Cheng IK
    Nephron; 1995; 71(3):321-7. PubMed ID: 8569982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment outcomes in refractory lupus nephritis: Data from an observational study.
    Gururani S; Devarasetti PK; Uppin M; Rajasekhar L
    Lupus; 2021 Oct; 30(11):1725-1731. PubMed ID: 34304627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multitarget Therapy for Maintenance Treatment of Lupus Nephritis.
    Zhang H; Liu Z; Zhou M; Liu Z; Chen J; Xing C; Lin H; Ni Z; Fu P; Liu F; Chen N; He Y; Liu J; Zeng C; Liu Z
    J Am Soc Nephrol; 2017 Dec; 28(12):3671-3678. PubMed ID: 28760751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal relapse in children and adolescents with childhood-onset lupus nephritis: a 20-year study.
    Chan EY; Yap DY; Wong WH; Wong SW; Lin KY; Hui FY; Li JY; Lam SS; Wong JK; Lai FF; Ho TW; Tong PC; Lai WM; Chan TM; Ma AL
    Rheumatology (Oxford); 2024 Apr; 63(4):953-961. PubMed ID: 37632777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longterm followup of childhood lupus nephritis.
    Hagelberg S; Lee Y; Bargman J; Mah G; Schneider R; Laskin C; Eddy A; Gladman D; Urowitz M; Hebert D; Silverman E
    J Rheumatol; 2002 Dec; 29(12):2635-42. PubMed ID: 12465165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
    Szeto CC; Kwan BC; Lai FM; Tam LS; Li EK; Chow KM; Gang W; Li PK
    Rheumatology (Oxford); 2008 Nov; 47(11):1678-81. PubMed ID: 18753192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term renal outcome and complications in South Africans with proliferative lupus nephritis.
    Ayodele OE; Okpechi IG; Swanepoel CR
    Int Urol Nephrol; 2013 Oct; 45(5):1289-300. PubMed ID: 23306862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
    Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; de Ramon Garrido E; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
    Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.